| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Dec 17, 2015 | Dec 21, 2015 | Vincent Aurentz Chief Business Officer | Buy | Epirus Biopharmaceuticals, Inc. | EPRS | $3.43 | $7,546 | +30.56% |
| Dec 09, 2015 | Dec 11, 2015 | Vincent Aurentz Chief Business Officer | Buy | Epirus Biopharmaceuticals, Inc. | EPRS | $3.85 | $10,780 | +50.00% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.